FibroBiologics, Inc.
FBLG
$0.26
-$0.02-5.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.65M | -18.50M | -13.22M | -7.67M | -11.16M |
| Total Depreciation and Amortization | 832.00K | 751.00K | 663.00K | 597.00K | 573.00K |
| Total Amortization of Deferred Charges | 625.00K | 625.00K | 625.00K | -- | -- |
| Total Other Non-Cash Items | 4.11M | 3.08M | -646.00K | -4.42M | -1.87M |
| Change in Net Operating Assets | -3.31M | -2.26M | -2.36M | -1.42M | 559.00K |
| Cash from Operations | -16.39M | -16.30M | -14.94M | -12.90M | -11.90M |
| Capital Expenditure | -262.00K | -361.00K | -366.00K | -219.00K | -184.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -262.00K | -361.00K | -366.00K | -219.00K | -184.00K |
| Total Debt Issued | 4.38M | 13.78M | 13.78M | 9.40M | 9.97M |
| Total Debt Repaid | -3.40M | -115.00K | -287.00K | -459.00K | -574.00K |
| Issuance of Common Stock | 6.59M | 45.00K | 4.69M | 4.69M | 7.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7.57M | 13.71M | 18.18M | 13.63M | 16.91M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.09M | -2.96M | 2.87M | 509.00K | 4.82M |